EDITORIAL SECTION

Articles

Genomics and Precision Medicine: Exploring the Role of Genomics in Identifying Genetic Markers for Disease Susceptibility and Treatment Response

The advent of genomics has ushered in a new era of healthcare characterized by a paradigm shift from onesizefitsall medicine to precision medicine This transformative approach leverages the power of genetic information to tailor medical interventions to individual patients optimizing treatment efficacy and minimizing adverse effects

EU Pharma Reform 2025 Explained: What Market Access Leaders Must Know for 2026-2029

What if your EU market exclusivity depends on launching your medicine in every member state and proving its realworld value This is no longer hypothetical The historic Pharma Reform agreement of the Council of the EU of March is the first major revision of pharmaceutical legislation in more than years It will have a significant impact on the way businesses will enter the market set their prices...

Advertise Smarter with the 2025 Pharma Focus Europe Media Pack

The internet has forever changed the healthcare industry and it is no longer whether to advertise but how to advertise better in the changing digital world Following the shift of pharma marketing to precision personalization and performance Pharma Focus Europe Media Pack is precisely your prescription to be the best in terms of competing in the European market

Building Resilient Pharma Supply Chains to Strengthen Patient Care

The failure to deliver a temperaturesensitive biologic or a critical maintenance drug on time is becoming a patient outcome crisis not just an operational inefficiency By fortifying our global logistics networks we proactively safeguard the availability of lifesaving therapies and essential healthcare supplies securing the healthcare industrys central promise to global health This strategic impera...

How to Mitigate Operational Risks in the Pharma Industry?

The operation of the pharmaceutical industry has significant risks with the most probable being operational risks These risks include supply chain interruption regulatory non compliance product defects technological disruption The development of strategies to avoid compromise in operations remains paramount not only in protecting the customers from harm or receiving

What Are the Implications of the Changing Regulatory Landscape in Europe?

In an age characterized by technological progress changing geopolitical scenarios and an increasing focus on sustainability businesses in Europe are grappling with an intricate network of regulatory shifts

Techno Trends

FDA Grants Breakthrough Therapy Designation to Calico's Fosigotifator

Calico Life Sciences LLC has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to fosigotifator for the treatment of Vanishing White Matter disease a rare and progressive neurological disorder with no approved therapies

Projects

Johnson & Johnson Invests $1B to Expand U.S. Vision Manufacturing & Distribution

Johnson Johnson has announced an investment of more than billion to expand its Vision manufacturing operations in Jacksonville Florida The project is designed to increase domestic manufacturing packaging and distribution capacity for the company

Research Insights

Predicting unknown binding sites for transition-metal-based compounds in proteins

Transitionmetalbased compounds are promising therapeutic agents particularly in cancer treatment However predicting the binding sites of such compounds remains a major challenge In this work we investigate the applicabilit

whitepaper

Placing the Right Bets: Defining Tailored Investment Strategies for Pharma Launch

Pharmaceutical launches have become significantly harder to execute successfully As IQVIAs new white paper highlights median six month cumulative sales for innovative launches have declined by compared with pre levels reflecting shrinking market opportunities